2024 Call Center Monitoring Performance Metrics for Timeliness Study, Quarter 1
Relevant to: All Medicare Advantage, Prescription Drug Plan, and Demonstration Organizations
April 2024 Memos
Extension of the HEDIS Data Submission Deadline
Relevant to: Medicare Advantage Organizations, Cost Plans, and Demonstrations
Continuation of the Prescription Drug Event (PDE) Reports and PDE Analysis Reporting Initiatives for the 2024 Benefit Year
Relevant to: All Part D Plan Sponsors
UPDATES – 2024 Medicare Part D Patient Safety Reports
Relevant to: All Prescription Drug Plans, Medicare Advantage-Prescription Drug
Plans, Section 1876 Cost Plans, and PACE plans
Contract Year 2025 Bid Review Out-of-Pocket Cost (OOPC) Models
Relevant to: Pharmaceutical Manufacturers; All Part D Plan Sponsors
Contract Year 2025 Bid Review Out-of-Pocket Cost (OOPC) Models
Relevant to: All Medicare Advantage Organizations and Part D Plan Sponsors
CY 2025 Part D Formulary Submission Information
Relevant to: All Prescription Drug Plans, Medicare Advantage-Prescription Drug Plans,
Section 1876 Cost Plans, Medicare-Medicaid Plans, and PACE Organizations
Prescription Drug Event Record Reporting Instructions for the Implementation of the Inflation Reduction Act for Contract Year 2025
Relevant to: All Part D Sponsors